Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05243836

S.T.O.P.® Technology Contact Lenses Versus Dual-focus Contact Lenses for Slowing Down Myopia Progression in Children

Contact Lenses Utilising S.T.O.P.® Technology Versus Dual-focus Contact Lenses for Slowing Down Myopia Progression in Children: A Three-year Prospective, Multi-centre, Controlled, Masked, Randomised, Non Inferiority Clinical Trial

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
441 (estimated)
Sponsor
nthalmic Pty Ltd · Network
Sex
All
Age
8 Years – 14 Years
Healthy volunteers
Not accepted

Summary

To compare the rate of myopia progression of contact lenses utilising S.T.O.P.® technology against MiSight® contact lenses.

Detailed description

Myopic children (8-14 years of age) will be randomly allocated to wear one of 3 contact lens options (MiSight®, S.T.O.P.®- F2 or S.T.O.P.®- DT) bilaterally on a daily wear basis. The overall trial duration, including follow-up period, is expected to be approximately 48 months. Each participant's duration is expected to be approximately 36 months. The visits are Baseline / Fit, Dispensing, 1 week, 1 month, 6 months then visits every 6 months after. All procedures performed at these visits are standard, non invasive clinical tests.

Conditions

Interventions

TypeNameDescription
DEVICES.T.O.P® F2Ocufilcon D, 55% water
DEVICES.T.O.P® DTOcufilcon D, 55% water
DEVICEMiSight®Omafilcon A (60% water)

Timeline

Start date
2023-08-04
Primary completion
2028-01-01
Completion
2028-01-01
First posted
2022-02-17
Last updated
2026-03-05

Locations

7 sites across 3 countries: China, India, Spain

Source: ClinicalTrials.gov record NCT05243836. Inclusion in this directory is not an endorsement.

S.T.O.P.® Technology Contact Lenses Versus Dual-focus Contact Lenses for Slowing Down Myopia Progression in Children (NCT05243836) · Clinical Trials Directory